Preventing Perinatal Depression with an App-Based CBT Program
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorJintang County Maternal and Child Health Hospital
About this trial
The goal of this clinical trial is to learn if CareMom, a mobile app-based cognitive behavioral therapy program works to prevent perinatal depression among Chinese mothers. The main questions the trial aims to answer are:
1. Does CareMom lower depression scores after an 8-week intervention? 2. Does CareMom lower depression scores at 6 weeks after childbirth? 3. How satisfied are participants with CareMom? 4. What unfavorable events, if any, are associated with the use of CareMom?
Researchers will compare CareMom to a matched attention control (a mobile app-based program that offers participants a similar level of interaction and daily activities) to see if CareMom works to prevent perinatal depression.
Participants will:
1. Engage in the CareMom program or a relaxation training program every day for 8 weeks 2. Complete a series of online questionnaire tests before and after the 8-week intervention. 3. Report any discomfort experienced throughout the study period.
Eligibility criteria
Qualifiers
aged 18-45 years
at 20-24 weeks of gestation
at risk of depression but not experiencing severe depressive symptoms at recruitment, as indicated by an Edinburgh Postnatal Depression Scale (EPDS) score of between 5 and 12
own a smartphone
Disqualifiers
have serious medical conditions or pregnancy complications that may affect their psychological condition, as determined by their medical doctor
have a prior diagnosis of any mental disorders
are currently or were recently (within the past six months) receiving any kinds of psychological services or treatments
have a history of self-harm or suicide
Trial design
Treatments tested in this trial
- CareMom (a mobile app-based 8-wekk cognitive behavioral therapy program)
- Matched Attention Control (a mobile app-based 8-week online relaxation training program)
Treatment groups
290 Participants
are divided into 2 treatment groupsSponsors and collaborators
Jintang County Maternal and Child Health Hospital
Lead sponsor
Chengdu Women's and Children's Central Hospital
Collaborator
Source ClinicalTrials.gov